Home > Health > Pharmacy > Drugs and Medications > B > Bosentan
Bosentan (under the brand name Tracleer by Actelion Pharmaceuticals) is the first approved endothelian receptor antagonist. It was approved by the FDA in November 2001 and is used in the treatment of Pulmonary Arterial Hypertension.
http://www.fda.gov/ohrms/dockets/ac/01/slides/3775S2_01_ACTELION/Index.htm
Actelion's slide show presentation to the FDA.
https://medlineplus.gov/druginfo/meds/a605001.html
Provides information on usage, precautions, side effects and brand names when available. Data provided by government agencies and health-related organizations
http://www.tracleer.com/
Features an overview of pulmonary hypertension, prescribing information for US residents, and press releases.
Home > Health > Pharmacy > Drugs and Medications > B > Bosentan
Thanks to DMOZ, which built a great web directory for nearly two decades and freely shared it with the web. About us